Daniel Verdon

4PUBLICATIONS
13CO-AUTHORS
Powder and particle technologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 29, 2026
A PepFect14 analog improves non-viral CRISPR delivery in primary human cells to facilitate genome editing and repair.

|Aug 27, 2021
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy.

Daniel J Verdon, Misty R Jenkins

|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.

Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey

|Oct 08, 2020
Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion.

Daniel J Verdon, Matthias Mulazzani, Misty R Jenkins

Pageof 1

Frequent Collaborators

2 joint publications

Misty R Jenkins

1 joint publications

Matthias Mulazzani

1 joint publications

Rebecca C Abbott

1 joint publications

Kylie Luong